Trials.ai

San Diego, United States Founded: 2014 • Age: 12 yrs Acquired By ZS
Provider of AI based trial management solution.

About Trials.ai

Trials.ai is a Healthcare company based in San Diego (United States) founded in 2014, and was acquired by ZS in February 2023. Provider of AI based trial management solution. It operates in the Healthcare and Technology sectors. Trials.ai offers products and services including Smart Study Platform and Smart Protocol Technology. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Hawthorne Effect, Strategikon Pharma and Drumroll Health.

Company details

Trials.ai was founded in 2014 in San Diego, United States, and operates in the healthcare technology sector. Artificial intelligence is utilized to support medical device and small pharmaceutical companies in clinical trial management. Repetitive tasks are automated, protocol-based events are generated to maintain data quality, and action recommendations are provided. A cloud-based platform delivers relevant insights to sponsors, contract research organizations, and trial sites across operations.

  • Headquarters San Diego, United States
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website trials.ai
  • Social LinkedIn X Facebook
  • Acquired by ZS (Feb 2023)
Key Metrics
  • Investors
    ZS

    & 6 more

  • Acquired by
    ZS

    (Feb 2023)

Products & Services of Trials.ai

Trials.ai offers a comprehensive portfolio of products and services, including Smart Study Platform and Smart Protocol Technology.

Smart Study Platform
AI Software

Platform mines trial data for insights and protocol optimization.

Smart Protocol Technology
AI Tool

Technology designs clinical trials using ML to reduce risks and costs.

Funding Insights of Trials.ai

  • Total Rounds 3
  • Investors Count 6

All 3 funding rounds of Trials.ai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2019Seed–Teal Ventures
Jun 2018Seed–Dreamit
–
Oct 2016Seed–EvoNexus
–
Valuation history

7 investors in total: 7 institutional.

Investors in Trials.ai

Trials.ai has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include ZS, Teal Ventures and Amplify.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage investments in health technology are facilitated by Teal Ventures.
teal-ventures.comSan Diego, United States
Investments are made in early to mid-stage technology companies.
swayvc.comSan Francisco, United States
Startup accelerator and incubator
nex3.comSan Francisco, United States
Startup accelerator
dreamit.comNew York, United States
12-18 month incubation programs are provided for startups in California.
evonexus.orgSan Diego, United States
Amplify is recognized as a pre-seed fund supporting tech entrepreneurs.
amplify-vc.comLos Angeles, United States
Strategic and management consulting services are provided worldwide.
1983zs.comEvanston, United States
Premium access

Investor details for Trials.ai

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Trials.ai

1 people are tracked at Trials.ai (1 in leadership).

NameRoleGroup
Kim Padilla Walpole
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Trials.ai

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Trials.ai

4 dated milestones of Trials.ai across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Trials.ai is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Seed,.
  4. Exit Acquired by ZS.

Competitors of Trials.ai

Trials.ai has 3 listed competitors in our database. They include Hawthorne Effect, Strategikon Pharma and Drumroll Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
hawthorneeffect.com2015Lafayette, United States11
Provides networks for accessible clinical trials with technology and site support.
strategikonpharma.com2016San Rafael, United States
Provides SaaS tools for streamlining clinical trial budgeting and vendor oversight.
drumroll.health2012New York, United States
Provider of patient engagement services
Premium access

Detailed competitors of Trials.ai

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Trials.ai

The website of Trials.ai (trials.ai) receives about 2.5K visits a month.

  • Monthly visits
    2.5K

    ▲ 30.4% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Trials.ai (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Trials.Ai

Trials.ai Lands Pre-Seed Round
Vcnewsdaily β€’ 6 years ago
Premium access

Complete news archive for Trials.ai

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trials.ai

Trials.ai was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Trials.ai is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Trials.ai was founded in 2014 in San Diego, United States, and operates in the healthcare technology sector. Artificial intelligence is utilized to support medical device and small pharmaceutical companies in clinical trial management. Repetitive tasks are automated, protocol-based events are generated to maintain data quality, and action recommendations are provided. A cloud-based platform delivers relevant insights to sponsors, contract research organizations, and trial sites across operations.

Trials.ai's top competitors include Drumroll Health, Hawthorne Effect and Strategikon Pharma.

Trials.ai offers Smart Study Platform and Smart Protocol Technology.

Trials.ai has 7 investors. Key investors include ZS, Teal Ventures, Amplify, Sway Ventures, and Nex Cubed.

Yes. Trials.ai was acquired by ZS in February 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available